Karl Baum

823 total citations
10 papers, 154 citations indexed

About

Karl Baum is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Karl Baum has authored 10 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Neurology and 3 papers in Rheumatology. Recurrent topics in Karl Baum's work include Peripheral Neuropathies and Disorders (5 papers), Multiple Sclerosis Research Studies (5 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Karl Baum is often cited by papers focused on Peripheral Neuropathies and Disorders (5 papers), Multiple Sclerosis Research Studies (5 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Karl Baum collaborates with scholars based in Germany, United States and Switzerland. Karl Baum's co-authors include Friedel M. Reischies, Carsten Schulte, R. Félix, W. Schörner, U. Hopf, Emerson Y. Chen, Sigurður Ólafsson, Richard Lund, Einar S. Björnsson and Arthur Löve and has published in prestigious journals such as Hepatology, Biological Psychiatry and Journal of the Neurological Sciences.

In The Last Decade

Karl Baum

10 papers receiving 147 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karl Baum Germany	6	46	42	34	33	26	10	154
Şebnem Kargı Türkiye	9	15 0.3×	23 0.5×	31 0.9×	20 0.6×	19 0.7×	17	293
P. Flores Chile	7	91 2.0×	18 0.4×	37 1.1×	27 0.8×	14 0.5×	9	187
Emilio Franco Spain	7	26 0.6×	59 1.4×	67 2.0×	18 0.5×	6 0.2×	14	204
Tania Amin Germany	6	13 0.3×	27 0.6×	42 1.2×	25 0.8×	33 1.3×	11	159
A Vérier France	8	80 1.7×	186 4.4×	22 0.6×	164 5.0×	11 0.4×	20	300
Valéria Coelho Santa Rita Pereira Brazil	7	27 0.6×	78 1.9×	29 0.9×	32 1.0×	10 0.4×	16	170
Pin Fee Chong Japan	9	29 0.6×	16 0.4×	20 0.6×	35 1.1×	9 0.3×	33	202
Süleyman Demırcan Türkiye	12	24 0.5×	16 0.4×	60 1.8×	45 1.4×	3 0.1×	26	358
Felipe Torres Pacheco Brazil	8	14 0.3×	20 0.5×	14 0.4×	81 2.5×	6 0.2×	29	223
Mar Mendibe Bilbao Spain	9	42 0.9×	147 3.5×	19 0.6×	62 1.9×	10 0.4×	18	210

Countries citing papers authored by Karl Baum

Since Specialization

Citations

This map shows the geographic impact of Karl Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Baum more than expected).

Fields of papers citing papers by Karl Baum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Baum. The network helps show where Karl Baum may publish in the future.

Co-authorship network of co-authors of Karl Baum

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Baum. A scholar is included among the top collaborators of Karl Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Baum. Karl Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Stascheit, Frauke, Linna Li, Knut Mai, et al.. (2020). Delayed onset hypophysitis after therapy with daclizumab for multiple sclerosis – A report of two cases. Journal of Neuroimmunology. 351. 577469–577469. 2 indexed citations

2.

Baum, Karl, et al.. (2016). Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerations. Drug Design Development and Therapy. Volume 10. 3379–3386. 6 indexed citations

3.

Chen, Emerson Y., Karl Baum, William Collins, et al.. (2012). Hepatitis E masquerading as drug-induced liver injury. Hepatology. 56(6). 2420–2423. 23 indexed citations

4.

Baum, Karl. (2009). Improving Patient Satisfaction with Injection Devices in Multiple Sclerosis Improves Adherence. European Neurological Review. 4(2). 64–64. 1 indexed citations

5.

Zettl, Uwe K., Wolfgang Köhler, Johannes Buchmann, et al.. (2007). Multiple Sklerose im Kindes- und Jugendalter. 1 indexed citations

6.

Baum, Karl, et al.. (1996). Incidental white-matter foci on MRI in "healthy" subjects: evidence of subtle cognitive dysfunction. Neuroradiology. 38(8). 755–760. 59 indexed citations

7.

Baum, Karl, et al.. (1994). Mixed connective tissue disease: recurrent episodes of optic neuropathy and transverse myelopathy. Successful treatment with plasmapheresis. Journal of the Neurological Sciences. 126(2). 146–148. 25 indexed citations

8.

Reischies, Friedel M., et al.. (1993). Psychopathological symptoms and magnetic resonance imaging findings in multiple sclerosis. Biological Psychiatry. 33(8-9). 676–678. 5 indexed citations

9.

Baum, Karl, et al.. (1993). Systemic lupus erythematosus: neuropsychiatric signs and symptoms related to cerebral MRI findings. Clinical Neurology and Neurosurgery. 95(1). 29–34. 26 indexed citations

10.

Baum, Karl & Richard Lund. (1974). Vertebral centra in Haplolepis (Haplolepidae, Paleonisciformes) from the Allegheny Group, Pennsylvanian. Journal of Paleontology. 48(1). 199–200. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact